GAM
MIRM icon

Gotham Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Gotham Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
2,385
-759
-24% -$76.2K ﹤0.01% 1667
2026
Q1 		$290K Buy
+3,144
New +$296K ﹤0.01% 1611
2025
Q2 		– Sell
-6,043
Closed -$272K – 1714
2025
Q1 		$272K Buy
+6,043
New +$285K ﹤0.01% 1399

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gotham Asset Management's MIRM Position: Q2 2026 in Review

Gotham Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 24% in Q2 2026, selling an estimated $76.2K and leaving 2,385 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Gotham Asset Management first reported a position in MIRM in Q1 2025 and has held it in 3 quarters since. The position peaked at $290K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Gotham Asset Management held 2,385 shares of Mirum Pharmaceuticals worth $279K as of Q2 2026.
  • Gotham Asset Management sold 759 Mirum Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Gotham Asset Management's portfolio in Q2 2026, its #1667 holding.
  • Gotham Asset Management first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Gotham Asset Management's Mirum Pharmaceuticals position peaked at $290K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.